I. Tamm et al., IAP-family protein Survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs, CANCER RES, 58(23), 1998, pp. 5315-5320
Survivin is a member of the inhibitor of apoptosis protein (IAP) family. We
investigated the antiapoptotic mechanism of Survivin, as well as its expre
ssion in 60 human tumor cell Lines used for the National Cancer Institute's
anticancer drug screening program. In cotransfection experiments, cell dea
th induced by Bar or Fas (CD 95) was partially inhibited (mean +/- SD, 65%
+/- 8%) by Sunivin, whereas XIAP, another IAP family member, almost complet
ely blocked cell death (93% +/- 4%) under the same conditions. Survivin and
XIAP also protected 293 cells from apoptosis induced by overexpression of
procaspase-3 and -7 and inhibited the processing of these zymogens into act
ive caspases. In vitro binding experiments indicated that, like other IAP-f
amily proteins, Survivin binds specifically to the terminal effector cell d
eath proteases, caspase-3 and -7, but not to the proximal initiator proteas
e caspase-8. Using a cell-free system in which cytosolic extracts were deri
ved from control- or Survivin-transfected cells and where caspases were act
ivated either by addition of cytochrome c and dATP or by adding recombinant
active caspase-8, Survivin was able to substantially reduce caspase activi
ty, as measured by cleavage of a tetrapeptide substrate, AspGluValAsp-amino
fluorocoumarin. Similar results were obtained in intact cells when Survivin
was overexpressed by gene transfection and caspase activation was induced
by the anticancer drug etoposide. Sunivin was expressed in all 60 cancer ce
ll lines analyzed, with highest levels in breast and lung cancers and lowes
t Levels in renal cancers. These findings indicate that Survivin, which is
commonly expressed in human tumor cell lines, can bind the effector cell de
ath proteases caspase-3 and -7 in vitro and inhibits caspase activity and c
ell death in cells exposed to diverse apoptotic stimuli. Although quantitat
ive differences may exist, these observations suggest commonality in the me
chanisms used by IAP-family proteins to suppress apoptosis.